PocDoc Leads UK in Digital Heart Risk Screening

By

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

UK-based PocDoc has become the leading provider of QRISK3 scores outside GP surgeries, revolutionizing cardiovascular disease (CVD) screening through its phone-based ‘Healthy Heart Check’ platform.

Key Milestones:

  • Delivers QRISK3 scores, cholesterol profile, BMI, and heart age via finger-prick test.
  • Adopted by NHS regions and retail partners like Superdrug, Well Pharmacy, and Pharmacy2U.
  • Fully integrated with the NHS App for streamlined care pathways.
  • Partnered with Endeavour Predict CIC to scale national CVD risk assessments.

Recommended by NICE, QRISK3 is the standard tool for predicting 10-year risk of heart attack or stroke. PocDoc’s service delivers results in minutes — a process that traditionally takes weeks — while unburdening GPs and saving the NHS up to £27 billion over the next decade.

PocDoc aims to help 500,000+ people manage heart health by 2025, marking a new era of accessible, preventative digital care.

Follow MEDWIRE.AI for breakthroughs in digital diagnostics.